Evaluation of Super-Boosted Lopinavir/Ritonavir in combination with Rifampin in HIV-1-infected Patients with Tuberculosis
Rifampin induces the metabolism of many medications. To overcome the reduction in serum concentrations of lopinavir/ritonavir (LPV/r) when used with rifampin, 800/200 mg or 400/400 mg doses are used. To evaluate the super-boosted LPV/r (400/400mg) combination in HIV-TB patients for adeq...read more
Mentioned in this Paper
References currently unavailable
We're still populating references for this paper, please check back later.
No citations available
This paper may not have been cited yet.